These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38074677)

  • 1. Differentiation between small hepatocellular carcinoma (<3 cm) and benign hepatocellular lesions in patients with Budd-Chiari syndrome: the role of multiparametric MR imaging.
    Zandieh G; Shahbazian H; Tang H; Wu Q; Shaghaghi M; Hazhirkarzar B; Baghdadi A; Afyouni S; Verde F; Pawlik T; Kamel I
    Front Oncol; 2023; 13():1282181. PubMed ID: 38074677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatobiliary MR contrast agents are useful to diagnose hepatocellular carcinoma in patients with Budd-Chiari syndrome.
    Van Wettere M; Paulatto L; Raynaud L; Bruno O; Payancé A; Plessier A; Rautou PE; Paradis V; Cazals-Hatem D; Valla D; Vilgrain V; Ronot M
    JHEP Rep; 2020 Jun; 2(3):100097. PubMed ID: 32435753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low specificity of washout to diagnose hepatocellular carcinoma in nodules showing arterial hyperenhancement in patients with Budd-Chiari syndrome.
    Van Wettere M; Purcell Y; Bruno O; Payancé A; Plessier A; Rautou PE; Cazals-Hatem D; Valla D; Vilgrain V; Ronot M
    J Hepatol; 2019 Jun; 70(6):1123-1132. PubMed ID: 30654065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benign hepatic nodules in Budd-Chiari syndrome: radiologic-pathologic correlation with emphasis on the central scar.
    Maetani Y; Itoh K; Egawa H; Haga H; Sakurai T; Nishida N; Ametani F; Shibata T; Kubo T; Tanaka K; Konishi J
    AJR Am J Roentgenol; 2002 Apr; 178(4):869-75. PubMed ID: 11906865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR imaging features and long-term evolution of benign focal liver lesions in Budd-Chiari syndrome and Fontan-associated liver disease.
    Panvini N; Dioguardi Burgio M; Sartoris R; Maino C; Van Wettere M; Plessier A; Payancé A; Rautou PE; Ladouceur M; Vilgrain V; Ronot M
    Diagn Interv Imaging; 2022 Feb; 103(2):111-120. PubMed ID: 34654671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Budd-Chiari syndrome: spectrum of appearances of acute, subacute, and chronic disease with magnetic resonance imaging.
    Noone TC; Semelka RC; Siegelman ES; Balci NC; Hussain SM; Kim PN; Mitchell DG
    J Magn Reson Imaging; 2000 Jan; 11(1):44-50. PubMed ID: 10676619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH; Kim SH; Park MJ; Park CK; Rhim H
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic nodules in Budd-Chiari syndrome: imaging features.
    Vilgrain V; Lewin M; Vons C; Denys A; Valla D; Flejou JF; Belghiti J; Menu Y
    Radiology; 1999 Feb; 210(2):443-50. PubMed ID: 10207428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Texture analysis of diffusion-weighted magnetic resonance imaging to identify atypically enhanced small hepatocellular carcinoma and dysplastic nodules under the background of cirrhosis].
    Zhong X; Li JS; Chen ZJ; Yin JX; Gui S; Sun ZQ; Tang HS
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jan; 28(1):37-42. PubMed ID: 32023697
    [No Abstract]   [Full Text] [Related]  

  • 10. Contrast-enhanced MR angiography of benign regenerative nodules following TIPS shunt procedure in Budd-Chiari syndrome.
    Tanju S; Erden A; Ceyhan K; Soygür IT; Bozkaya H; Erden I
    Turk J Gastroenterol; 2004 Sep; 15(3):173-7. PubMed ID: 15492917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using receiver operating characteristic curves to evaluate the diagnostic value of the combination of multislice spiral CT and alpha-fetoprotein levels for small hepatocellular carcinoma in cirrhotic patients.
    Jia GS; Feng GL; Li JP; Xu HL; Wang H; Cheng YP; Yan LL; Jiang HJ
    Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):303-309. PubMed ID: 28603099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation-induced liver injury showing low intensity on T2-weighted images noted in Budd-Chiari syndrome.
    Mori H; Yoshioka H; Mori K; Ahmadi T; Okumura T; Saida Y; Itai Y
    Radiat Med; 2002; 20(2):69-76. PubMed ID: 12041701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of imaging characteristics between hepatic benign regenerative nodules and hepatocellular carcinomas associated with Budd-Chiari syndrome by contrast enhanced ultrasound.
    Zhang R; Qin S; Zhou Y; Song Y; Sun L
    Eur J Radiol; 2012 Nov; 81(11):2984-9. PubMed ID: 22341409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of hepatocellular carcinoma in Egyptian patients with primary Budd-Chiari syndrome.
    Sakr M; Abdelhakam SM; Dabbous H; Hamed A; Hefny Z; Abdelmoaty W; Shaker M; El-Gharib M; Eldorry A
    Liver Int; 2017 Mar; 37(3):415-422. PubMed ID: 27507647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver.
    Holland AE; Hecht EM; Hahn WY; Kim DC; Babb JS; Lee VS; West AB; Krinsky GA
    Radiology; 2005 Dec; 237(3):938-44. PubMed ID: 16306035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the diffusion sequence in magnetic resonance imaging for the differential diagnosis between hepatocellular carcinoma and benign liver lesions.
    Caraiani CN; Marian D; Militaru C; Calin A; Badea R
    Clujul Med; 2016; 89(2):241-9. PubMed ID: 27152076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative liver magnetic resonance imaging: correlation between conventional magnetic resonance imaging, laboratory values, and prognostic indices in Budd-Chiari syndrome.
    Erden A; Kuru Öz D; Adıgüzel M; Özalp Ateş FS
    Diagn Interv Radiol; 2023 May; 29(3):428-436. PubMed ID: 36960638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma in Budd-Chiari syndrome: enhancement patterns at dynamic gadolinium-enhanced T1-weighted MR imaging.
    Yang C; Xu K; Zheng J; Ma P; Hu C; Li S; Rong Y; Lu X; Zhang Q; Zu M; Hua R; Zhang L
    Cell Biochem Biophys; 2014 Sep; 70(1):661-6. PubMed ID: 24760630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Added Value of Quantitative Apparent Diffusion Coefficients for Identifying Small Hepatocellular Carcinoma from Benign Nodule Categorized as LI-RADS 3 and 4 in Cirrhosis.
    Zhong X; Tang H; Guan T; Lu B; Zhang C; Tang D; Li J; Cui S
    J Clin Transl Hepatol; 2022 Feb; 10(1):34-41. PubMed ID: 35233371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.